Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing voriconazole and intermediate thereof

A technology of voriconazole and intermediates, applied in the field of drug synthesis, can solve the problems of harsh preparation conditions and unfavorable industrial production, and achieve the effect of short route, mild reaction conditions and wide application

Active Publication Date: 2012-12-05
NANJING HUAWE MEDICINE TECH DEV
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The super base n-butyllithium is used in the preparation process, and the preparation conditions are harsh, which is not conducive to industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing voriconazole and intermediate thereof
  • Method for preparing voriconazole and intermediate thereof
  • Method for preparing voriconazole and intermediate thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1: Preparation of α-(5-fluoropyrimidin-4-yl)-2,4-difluoropropiophenone (III)

[0038]

[0039] Add 6.33g of zinc powder and 25g of THF to the three-necked flask, add 9g of iodine in 25g of THF dropwise under the protection of nitrogen at room temperature, and stir at room temperature for 30min after the dropping is complete. Add 6.4 g of 4-(1-bromoethyl)-5-fluoropyrimidine, 4.88 g of 2,4-difluorobenzaldehyde and 0.88 g of iodine in 25 g of THF dropwise with stirring in an ice bath, and control the rate of addition to keep the reaction temperature at 0°C~5°C. After dropping, the temperature was slowly raised to room temperature and stirred for 5 h, then 50 mL of saturated sodium bisulfite solution was slowly added under stirring in an ice bath, and stirred for 30 min. Filtration, the filtrate was distilled to dryness under reduced pressure, 20 mL of dichloromethane was added to the residue, the organic layer was separated, and 50 mL of saturated NaHCO 3solut...

Embodiment 2

[0040] Example 2: Preparation of α-(5-fluoropyrimidin-4-yl)-2,4-difluoropropiophenone (III)

[0041] Add 3.2Kg of zinc powder and 13Kg of THF to the reaction kettle, add 13Kg of THF solution of 5Kg of iodine dropwise under the protection of nitrogen at room temperature, and stir at room temperature for 30min after the dropping is completed. Add 3.3Kg of 4-(1-bromoethyl)-5-fluoropyrimidine, 2.44Kg of 2,4-difluorobenzaldehyde and 0.44Kg of iodine in 12KgTHF dropwise with stirring in an ice bath, and control the rate of addition to keep the reaction temperature at 0°C~10°C. After dropping, the temperature was slowly raised to room temperature and stirred for 5.5 hours. Then, 25 L of saturated sodium bisulfite solution was slowly added while stirring in an ice bath, and stirred for 30 minutes. Filtrate, recover THF from the filtrate under reduced pressure, add 2L dichloromethane to the residue, separate the organic layer, and use 25L saturated NaHCO 3 solution, 2×25L saturated N...

Embodiment 3

[0042] Example 3: Preparation of 1-bromomethyl-1,2,4-triazole (VI')

[0043]

[0044] Add 7.5LTHF and 630g NaH into the reaction kettle, slowly add 1050g of 1,2,4-triazole in batches under ice-bath stirring, and ice-bath stirring for 1h. Add dropwise the 500mLTHF solution of iodomethane 3300g, control the rate of addition, make the temperature of reaction remain on 5 ℃~10 ℃. After dropping, the temperature was slowly raised to room temperature and the reaction was stirred for 3h. Add 3300g of NBS and 4g of azobisisobutyronitrile into the reaction solution, and heat up to reflux for 20 hours under stirring. After cooling, the solvent was recovered under reduced pressure, 8L of dichloromethane was added to the residue, and 3×3L of saturated Na 2 CO 3 solution, 3×3L saturated NaCl solution, and dried over anhydrous magnesium sulfate. After filtration, the filtrate was decompressed and the solvent was recovered to dryness to obtain 1686 g of brown oily compound (VI'), yield...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for preparing voriconazole and intermediate thereof. The method comprises the following steps of: enabling the compound 4-(1-halogenated ethyl)-5-fluoropyrimidine in the formula (II) to react with 2,4-difluorobenzaldehyde to generate the compound alpha-(5-fluoropyrimidine-4-yl)-2,4-difluoroacetone in the formula (III); then reacting with the compound 1-halogen methyl-1,2,4-triazole in the formula (VI) to generate the compound 1-(1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidine-4-yl)-2-butanol in the formula (IV); and finally resolving to obtain the voriconazole, shown as the accompanying drawing, wherein R1 and R2 are respectively halogen. The method for preparing voriconazole is easy in raw material obtaining, moderate in reaction conditions, and short in steps; each reaction is the mature organic reaction; and the method is widely applied in industry, and has certain industrial production conditions.

Description

technical field [0001] The invention belongs to the field of drug synthesis, in particular to voriconazole and its intermediates α-(5-fluoropyrimidin-4-yl)-2,4-difluoropropiophenone (Ⅲ) and 1-(1,2,4- Preparation method of triazol-1-yl)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-2-butanol (IV). Background technique [0002] Voriconazole (voriconazole) [(2R,3S)-1-(1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidine- 4-yl)-2-butanol] is a new generation of triazole broad-spectrum antifungal drug developed by Pfizer, mainly used for the treatment of systemic deep fungal infectious diseases caused by Aspergillus, Cryptococcus and Candida. Voriconazole is considered to have a very broad market prospect because of its unique pharmacodynamic characteristics and good clinical application effect. The compound is represented by the following formula (I): [0003] [0004] In EP0440372A1, 6-chloro-5-fluoro-4-ethylpyrimidine is used as the starting material, whi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D403/06
Inventor 蒋玉伟包金远张孝清肖涛
Owner NANJING HUAWE MEDICINE TECH DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com